Parkinson’s
Disease Drug Market is expected to grow at a significant CAGR in
the upcoming years as the scope and its applications are rising enormously
across the globe. Parkinson’s disease (PD) is termed as a neurodegenerative
disorder that affects dopaminergic neurons in a precise area of the brain
called substantia nigra. Medicines are the most common treatment for
Parkinson’s disease. There are numerous drugs available to treat both motor and
non-motor symptoms of Parkinson ’s disease and all are directed at easing
symptoms and improving quality of life.
Browse Full TOC of
This Report @ https://www.millioninsights.com/industry-reports/Parkinson-s-disease-pd-drug-market
The factors that are playing a
major role in the growth of Parkinson's Disease Drug Market are rising life
expectancy, rising funding support & research grants, growing healthcare
expenditure, and rising awareness. In addition, growing old age population and
rising incidences of neurodegenerative diseases are the other factors driving
the industry. On the other hand, the high cost of treatment, lack of expertise,
and side effects of drugs are the factors restraining overall market growth.
Parkinson's Disease Drug
Market is segmented based on drug types, distribution channel, end users,
applications, and region. Drug types such as Anticholinergics (Benztropine or
Trihexyphenidyl), Levodopa/Carbidopa, COMT-Inhibitors (Entacapone, Tolcapone),
Amantadine, Dopamine Agonists (Ropinirole or Pramipexole), MAO-B Inhibitors
(Selegiline, Rasagiline), Apomorphine, and others classify this market.
The key players of Parkinson's
Disease Drug Industry are Valeant Pharmaceuticals, GSK, US WorldMeds, Novartis,
StadaArzneimittel, BoehringerIngelheim, Orion, Teva Pharmaceutical, Apokyn,
Abbvie, Valeant, Merck, Lundbeck, Akorn, Hoffmann-La Roche, Kyowa Hakko Kirin
Pharma, Endo Pharmaceuticals, Astellas Pharma, and DesitinArzneimittel. These
players are concentrating on inorganic growth to sustain themselves amongst
fierce competition. As such, mergers, acquisitions, and joint ventures are the
need of the hour.
Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/Parkinson-s-disease-pd-drug-market/request-sample
No comments:
Post a Comment